https://doi.org/10.1074/jbc.m114.589002
P
Philippe Ferber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
780
Citations
13
h-index
19
i10-index
Philippe Ferber is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Complement system in diseases & Lipoproteins and Cardiovascular Health & Blood Pressure and Hypertension Studies. The author has an h-index of 13, co-authored 36 publications.
Papers by this author
worksDefinition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
2014 · Journal of Biological Chemistry · 30 citations
Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank
2023 · Atherosclerosis · 29 citations
https://doi.org/10.1016/j.atherosclerosis.2023.117437
Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin
1996 · FEBS Letters · 19 citations
https://doi.org/10.1016/0014-5793(96)00609-6
Outcomes with Sacubitril/Valsartan in Outpatients with Heart Failure and Reduced Ejection Fraction: The ARIADNE Registry
2022 · ESC Heart Failure · 8 citations
https://doi.org/10.1002/ehf2.14014
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial
2026 · European Heart Journal · 0 citations
https://doi.org/10.1093/eurheartj/ehag073
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat